ABBV has strong fundamentals and management but current valuation at 272 is unconvincing for new purchases.
Jump to any passage
the next The company on the list AbbVie. This is one of the first individual stocks that I absolutely bought it. It is actually the center Longer single Keep it in my wallet
The company on the list AbbVie. This is one of the first individual shares that I absolutely bought it. It is actually the center Longer single Keep it in my wallet . Um, it's just a name.
Wonderful, he did a number Things. I have moved Because it depends on The first leading drug Humira to the works More diverse now with " Rinvoq and Skyrizi and things Something like that.
Therefore, Excellent management. Greetings to them. The score is 72 here. I agree However, at a price of 272, The evaluation is not Convincing as it should be. So This reduces the score From that perspective, but Overall, it's strong.
What this channel has said about $ABBV
Mark Roussin, CPA has 2 calls on this stock; only the adjacent ones are shown.